INVA logo

Innoviva (INVA) EBITDA

annual EBITDA:

$85.50M-$149.54M(-63.62%)
December 31, 2024

Summary

  • As of today (June 30, 2025), INVA annual EBITDA is $85.50 million, with the most recent change of -$149.54 million (-63.62%) on December 31, 2024.
  • During the last 3 years, INVA annual EBITDA has fallen by -$378.85 million (-81.59%).
  • INVA annual EBITDA is now -81.59% below its all-time high of $464.35 million, reached on December 31, 2021.

Performance

INVA EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherINVAincome statement metrics

quarterly EBITDA:

-$27.40M-$63.36M(-176.22%)
March 31, 2025

Summary

  • As of today (June 30, 2025), INVA quarterly EBITDA is -$27.40 million, with the most recent change of -$63.36 million (-176.22%) on March 31, 2025.
  • Over the past year, INVA quarterly EBITDA has dropped by -$84.82 million (-147.73%).
  • INVA quarterly EBITDA is now -109.35% below its all-time high of $293.03 million, reached on September 30, 2022.

Performance

INVA quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherINVAincome statement metrics

TTM EBITDA:

$681.00K-$84.82M(-99.20%)
March 31, 2025

Summary

  • As of today (June 30, 2025), INVA TTM EBITDA is $681.00 thousand, with the most recent change of -$84.82 million (-99.20%) on March 31, 2025.
  • Over the past year, INVA TTM EBITDA has dropped by -$242.40 million (-99.72%).
  • INVA TTM EBITDA is now -99.87% below its all-time high of $508.80 million, reached on September 30, 2021.

Performance

INVA TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherINVAincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

INVA EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-63.6%-147.7%-99.7%
3 y3 years-81.6%-157.4%-99.8%
5 y5 years-67.8%-126.6%-99.8%

INVA EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-81.6%at low-109.3%+51.6%-99.8%at low
5 y5-year-81.6%at low-109.3%+51.6%-99.9%at low
alltimeall time-81.6%+148.9%-109.3%+51.6%-99.9%+100.4%

INVA EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
-$27.40M(-176.2%)
$681.00K(-99.2%)
Dec 2024
$85.50M(-63.6%)
$35.95M(+87.6%)
$85.50M(-30.6%)
Sep 2024
-
$19.17M(-170.9%)
$123.21M(-38.7%)
Jun 2024
-
-$27.04M(-147.1%)
$200.90M(-17.4%)
Mar 2024
-
$57.41M(-22.1%)
$243.08M(+3.4%)
Dec 2023
$235.04M(-23.8%)
$73.66M(-23.9%)
$235.04M(+124.3%)
Sep 2023
-
$96.86M(+539.5%)
$104.79M(-65.2%)
Jun 2023
-
$15.14M(-69.3%)
$300.96M(-2.9%)
Mar 2023
-
$49.37M(-187.2%)
$309.96M(+0.5%)
Dec 2022
$308.32M(-33.6%)
-$56.59M(-119.3%)
$308.32M(-27.7%)
Sep 2022
-
$293.03M(+1113.4%)
$426.24M(+61.1%)
Jun 2022
-
$24.15M(-49.4%)
$264.63M(-31.2%)
Mar 2022
-
$47.73M(-22.2%)
$384.87M(-18.9%)
Dec 2021
$464.35M(+24.6%)
$61.33M(-53.3%)
$474.72M(-6.7%)
Sep 2021
-
$131.43M(-9.0%)
$508.80M(+16.7%)
Jun 2021
-
$144.38M(+4.9%)
$435.93M(+4.4%)
Mar 2021
-
$137.59M(+44.2%)
$417.68M(+9.1%)
Dec 2020
$372.58M(+40.4%)
$95.41M(+63.0%)
$382.96M(+4.6%)
Sep 2020
-
$58.55M(-53.6%)
$365.98M(-1.9%)
Jun 2020
-
$126.14M(+22.6%)
$373.05M(+19.7%)
Mar 2020
-
$102.86M(+31.2%)
$311.61M(+17.4%)
Dec 2019
$265.43M(+7.0%)
$78.43M(+19.5%)
$265.43M(-1.0%)
Sep 2019
-
$65.62M(+1.4%)
$268.19M(+2.6%)
Jun 2019
-
$64.70M(+14.1%)
$261.44M(-0.7%)
Mar 2019
-
$56.68M(-30.2%)
$263.31M(+6.1%)
Dec 2018
$248.08M(+29.3%)
$81.19M(+37.9%)
$248.08M(+4.6%)
Sep 2018
-
$58.87M(-11.6%)
$237.26M(+9.9%)
Jun 2018
-
$66.56M(+60.6%)
$215.91M(+7.9%)
Mar 2018
-
$41.45M(-41.1%)
$200.19M(+4.3%)
Dec 2017
$191.86M(+52.3%)
$70.37M(+87.5%)
$191.86M(+17.3%)
Sep 2017
-
$37.52M(-26.2%)
$163.55M(+3.7%)
Jun 2017
-
$50.84M(+53.5%)
$157.66M(+14.2%)
Mar 2017
-
$33.12M(-21.3%)
$138.05M(+9.6%)
Dec 2016
$126.00M(+168.2%)
$42.06M(+33.0%)
$126.00M(+20.3%)
Sep 2016
-
$31.63M(+1.2%)
$104.77M(+23.1%)
Jun 2016
-
$31.24M(+48.2%)
$85.11M(+36.1%)
Mar 2016
-
$21.07M(+1.2%)
$62.53M(+33.1%)
Dec 2015
$46.98M(-292.0%)
$20.83M(+74.2%)
$46.98M(+79.0%)
Sep 2015
-
$11.96M(+38.1%)
$26.24M(+244.7%)
Jun 2015
-
$8.66M(+56.8%)
$7.61M(-208.1%)
Mar 2015
-
$5.52M(+5712.6%)
-$7.04M(-71.2%)
Dec 2014
-$24.46M
$95.00K(-101.4%)
-$24.46M(-19.2%)
Sep 2014
-
-$6.66M(+11.2%)
-$30.27M(-2.9%)
Jun 2014
-
-$5.99M(-49.6%)
-$31.16M(+32.4%)
DateAnnualQuarterlyTTM
Mar 2014
-
-$11.90M(+108.4%)
-$23.54M(-46.9%)
Dec 2013
-$17.83M(-16.8%)
-$5.71M(-24.4%)
-$44.37M(-45.0%)
Sep 2013
-
-$7.55M(-565.6%)
-$80.63M(-22.8%)
Jun 2013
-
$1.62M(-105.0%)
-$104.38M(-25.4%)
Mar 2013
-
-$32.73M(-22.0%)
-$139.96M(+628.0%)
Dec 2012
-$21.43M(-78.9%)
-$41.97M(+34.1%)
-$19.22M(+80.8%)
Sep 2012
-
-$31.30M(-7.8%)
-$10.63M(+66.1%)
Jun 2012
-
-$33.96M(-138.6%)
-$6.40M(-210.8%)
Mar 2012
-
$88.01M(-363.6%)
$5.78M(-105.7%)
Dec 2011
-$101.74M(+42.3%)
-$33.38M(+23.3%)
-$101.74M(+20.4%)
Sep 2011
-
-$27.07M(+24.3%)
-$84.51M(+11.8%)
Jun 2011
-
-$21.78M(+11.7%)
-$75.59M(+5.7%)
Mar 2011
-
-$19.51M(+20.8%)
-$71.48M(+0.0%)
Dec 2010
-$71.48M(-4.3%)
-$16.15M(-11.0%)
-$71.48M(-4.1%)
Sep 2010
-
-$18.15M(+2.7%)
-$74.56M(-1.9%)
Jun 2010
-
-$17.68M(-9.4%)
-$76.00M(-3.0%)
Mar 2010
-
-$19.50M(+1.4%)
-$78.32M(+4.9%)
Dec 2009
-$74.67M(-7.6%)
-$19.23M(-1.9%)
-$74.67M(+7.6%)
Sep 2009
-
-$19.59M(-2.0%)
-$69.40M(+0.9%)
Jun 2009
-
-$20.00M(+26.1%)
-$68.79M(+0.8%)
Mar 2009
-
-$15.86M(+13.7%)
-$68.22M(-15.6%)
Dec 2008
-$80.82M(-50.9%)
-$13.95M(-26.5%)
-$80.82M(-18.5%)
Sep 2008
-
-$18.98M(-2.3%)
-$99.19M(-13.1%)
Jun 2008
-
-$19.43M(-31.7%)
-$114.13M(-19.4%)
Mar 2008
-
-$28.46M(-11.9%)
-$141.58M(-13.9%)
Dec 2007
-$164.51M(-6.0%)
-$32.31M(-4.7%)
-$164.51M(-4.5%)
Sep 2007
-
-$33.92M(-27.6%)
-$172.31M(-3.6%)
Jun 2007
-
-$46.88M(-8.8%)
-$178.78M(+1.8%)
Mar 2007
-
-$51.39M(+28.1%)
-$175.57M(+0.3%)
Dec 2006
-$174.97M(+20.3%)
-$40.11M(-0.7%)
-$174.97M(-1.6%)
Sep 2006
-
-$40.40M(-7.5%)
-$177.75M(+1.2%)
Jun 2006
-
-$43.67M(-14.0%)
-$175.70M(+7.0%)
Mar 2006
-
-$50.79M(+18.4%)
-$164.25M(+12.9%)
Dec 2005
-$145.45M(+47.5%)
-$42.90M(+11.9%)
-$145.45M(+12.6%)
Sep 2005
-
-$38.34M(+19.0%)
-$129.15M(+14.4%)
Jun 2005
-
-$32.22M(+0.7%)
-$112.93M(+1.0%)
Mar 2005
-
-$31.99M(+20.3%)
-$111.84M(+40.1%)
Dec 2004
-$98.58M(+46.6%)
-$26.60M(+20.2%)
-$79.85M(+49.9%)
Sep 2004
-
-$22.13M(-28.9%)
-$53.26M(+71.1%)
Jun 2004
-
-$31.13M
-$31.13M
Dec 2003
-$67.26M(-13.7%)
-
-
Dec 2002
-$77.96M(+45.0%)
-
-
Dec 2001
-$53.77M(-48.3%)
-
-
Dec 2000
-$103.93M
-
-

FAQ

  • What is Innoviva annual EBITDA?
  • What is the all time high annual EBITDA for Innoviva?
  • What is Innoviva annual EBITDA year-on-year change?
  • What is Innoviva quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Innoviva?
  • What is Innoviva quarterly EBITDA year-on-year change?
  • What is Innoviva TTM EBITDA?
  • What is the all time high TTM EBITDA for Innoviva?
  • What is Innoviva TTM EBITDA year-on-year change?

What is Innoviva annual EBITDA?

The current annual EBITDA of INVA is $85.50M

What is the all time high annual EBITDA for Innoviva?

Innoviva all-time high annual EBITDA is $464.35M

What is Innoviva annual EBITDA year-on-year change?

Over the past year, INVA annual EBITDA has changed by -$149.54M (-63.62%)

What is Innoviva quarterly EBITDA?

The current quarterly EBITDA of INVA is -$27.40M

What is the all time high quarterly EBITDA for Innoviva?

Innoviva all-time high quarterly EBITDA is $293.03M

What is Innoviva quarterly EBITDA year-on-year change?

Over the past year, INVA quarterly EBITDA has changed by -$84.82M (-147.73%)

What is Innoviva TTM EBITDA?

The current TTM EBITDA of INVA is $681.00K

What is the all time high TTM EBITDA for Innoviva?

Innoviva all-time high TTM EBITDA is $508.80M

What is Innoviva TTM EBITDA year-on-year change?

Over the past year, INVA TTM EBITDA has changed by -$242.40M (-99.72%)
On this page